The Journal of urology

publication venue for

Bladder lipoma. 2013
Acute kidney transplant failure following transurethral bladder polyp fulguration. 2005
Stump transureteroureterostomy in en bloc kidney transplantation. 2005
Metastatic carcinoid tumor of the prostate. 2002
Perineal prostatic cancer seeding following radioactive seed brachytherapy. 2001
Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors. 2000
Bilateral anterior ischemic optic neuropathy and branch retinal artery occlusion after radical prostatectomy. 1999
Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy. 1999
Pentosan induced cerebral sagittal sinus thrombosis: a variant of heparin induced thrombocytopenia. 1998
A positive urine opiate screen following intracavernosal papaverine injection. 1998
Nilutamide response after flutamide failure in post-orchiectomy progressive prostate cancer. 1998
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. 1998
Granulomatous mass in a nonrefluxing renal unit after bacillus Calmette-Guerin therapy for bladder cancer. 1997
Fat density in renal cell carcinoma: demonstration with computerized tomography. 1997
Laparoscopic live donor nephrectomy: the initial 3 cases. 1996
Spontaneous drainage of an appendiceal abscess into an orthotopic neobladder. 1996
Laparoscopic laser assisted auto-augmentation of the pediatric neurogenic bladder: early experience with urodynamic followup. 1996
Fungal infections of the perivesical space. 1995
Coexisting lymphangioleiomyomatosis and bilateral angiomyolipomas in a patient with tuberous sclerosis. 1994
Intracardiac teratoma 15 years after treatment of a nonseminomatous germ cell tumor. 1993
A case of simultaneous bilateral nonseminomatous testicular tumors in persistent müllerian duct syndrome. 1992
Elevated plasma chromogranin-A concentrations in prostatic carcinoma. 1991
Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer. 1990
Hormone-secreting metastatic interstitial cell tumor of the testis. 1989
Testicular metastasis as the first manifestation of colon carcinoma. 1988
Giant posterior urethral diverticulum after radical retropubic prostatectomy. 1988
Unusual presentation of sigmoid diverticulitis as an acute scrotum. 1988
Neuropathy and orchialgia in a 40-year-old man. 1987
Flow cytometric analysis of primary adenocarcinoma of the bladder. 1987
Residual mass after chemotherapy for seminoma: changing concepts of management. 1987
Assessment of a retroperitoneal mass by magnetic resonance imaging in a 65-year-old woman. 1986
Testicular sarcoidosis: case report and review of the literature. 1986
An 18-year-old woman born with cloacal exstrophy. 1986
Condyloma acuminatum of the bladder and associated urothelial malignancy. 1985
Solitary crossed renal ectopia. 1985
Bilateral synchronous germ cell tumors. 1985
Nutritional support in a general urological service. 1984
Low dose thrombolysis: a nonoperative approach to renal artery occlusion. 1983
Ketoconazole: a novel and rapid treatment for advanced prostatic cancer. 1983
The significance of lymph nodal involvement in renal angiomyolipoma. 1982
Renovascular hypertension associated with a pelvic kidney and multicystic dysplasia. 1982
Clinicopathological conference: renal pelvic filling defect in a diabetic woman. 1982
Penile prosthesis for impotence: case report. 1981
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma. 1980
Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience. 1980
Innominate bone and renal masses in a young man. 1978
The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors. 1978
Advances in the diagnosis of renal candidiasis. 1978
Inflammatory fibrous histiocytoma presenting as a renal pelvic and bladder mass. 1977
Segmental renal vein renin assay and segmental nephrectomy for correction of renal hypertension. 1976
Reply: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From National Health and Nutrition Examination Survey. 2025
Reply: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From the National Health and Nutrition Examination Survey. 2025
Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-preserving Trimodality Therapy. 2025
Reply by Authors. 2025
Cross-Sectional Association of Time Spent Outdoors with Serum Testosterone: Results from NHANES. 2025
Reply by Authors.. 214. 2025
Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive Value.. 214. 2025
Is There a Winner? Prospective Randomized Controlled Trial Comparing SuperPulse Thulium Fiber Laser vs Pulse-Modulated High-Power Holmium:YAG Laser for Retrograde Intrarenal Surgery.. 213. 2025
Reply by Authors. 2024
Reply by Authors.. 211. 2024
Gabapentin for Postoperative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical Trial.. 211. 2024
Timing of Testicular Biopsy in Relation to Oocyte Retrieval and the Outcomes of Intracytoplasmic Sperm Injection. 2024
Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome. 2023
Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma.. 211. 2023
Same-Day Discharge vs Inpatient Robotic-Assisted Radical Prostatectomy: Complications, Time-Driven Activity-Based Costing, and Patient Satisfaction.. 210. 2023
Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial.. 210. 2023
Clinically Important Differences for Pain and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study.. 209. 2023
Utility of MRI for Localizing Prostate Cancer near the Urethra in Men Who are Candidates for Focal Gland Ablation. 2023
Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference? 2023
National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy.. 209. 2022
First Series Using Ultrasonic Propulsion and Burst Wave Lithotripsy to Treat Ureteral Stones.. 208. 2022
A Deception Study to Avoid Recall Bias Confirms Similar Scores for 3 Validated Questionnaires in the Office or Over the Phone in Women With or Without Urinary Incontinence.. 208. 2022
Impact of Left-digit Age Bias in the Treatment of Localized Prostate Cancer. 2022
Effects of Chemo- and Radiation Therapy on Microsurgical Testicular Sperm Extraction for Men with Non-obstructive Azoospermia. 2022
The Lived Experience of Patients with Adult Acquired Buried Penis.. 208. 2022
Tailored Feedback Based on Clinically Relevant Performance Metrics Expedites the Acquisition of Robotic Suturing Skills-An Unblinded Pilot Randomized Controlled Trial.. 208. 2022
ALDH2 Expression, Alcohol Intake and Semen Parameters among East Asian Men.. 208. 2022
Is Pelvic Floor Muscle Tenderness a Distinct Urologic Chronic Pelvic Pain Syndrome Phenotype? Findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Symptom Pattern Study.. 208. 2022
Reliability and Validity of Pain and Urinary Symptom Severity Assessment in Urological Chronic Pelvic Pain: A MAPP Network Analysis.. 207. 2022
Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide.. 207. 2022
Utility and Outcome of Angioembolization for High-Grade Renal Trauma Management in a Large Hospital-Based Trauma Registry.. 207. 2022
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.. 207. 2021
Incidence of Kidney Stones in the United States: The Continuous National Health and Nutrition Examination Survey.. 207. 2021
Urethroscopic Findings following Urethroplasty Predict the Need for Secondary Intervention in the Long Term: A Multi-Institutional Study from Trauma and Urologic Reconstructive Network of Surgeons.. 207. 2021
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.. 207. 2021
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.. 207. 2021
Quantifying Heterogeneity of Testicular Histopathology in Men with Nonobstructive Azoospermia. 2021
Comparative Outcomes of Salvage Retzius-Sparing versus Standard Robotic Prostatectomy: An International, Multi-Surgeon Series.. 206. 2021
Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy.. 206. 2021
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer.. 206. 2021
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies.. 206. 2021
Standing Ultrasound Adds Clinical Utility for the Diagnosis of Varicoceles.. 206. 2021
Adoption, Safety, and Retreatment Rates of Prostatic Urethral Lift for Benign Prostatic Enlargement.. 206. 2021
Contemporary Trends and End-Results of National Institutes of Health Grant Funding to Departments of Urology in the United States: A 10-year Analysis.. 206. 2021
Temporal Relationships between Pain, Mood and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study.. 205. 2021
An Objective Assessment of Performance during Robotic Partial Nephrectomy: Validation and Correlation of Automated Performance Metrics with Intraoperative Outcomes.. 205. 2020
Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data.. 205. 2020
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.. 205. 2020
Safety and Efficacy of Outpatient Surgical Procedures for the Treatment of Benign Prostatic Enlargement in New York State and California (2005-2016).. 205. 2020
Efficacy of Daily Intake of Dried Cranberry 500 mg in Women with Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled Study.. 205. 2020
Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes following Radical Cystectomy.. 205. 2020
A Novel Dissection Gesture Classification to Characterize Robotic Dissection Technique for Renal Hilar Dissection.. 205. 2020
Long-Term Safety with Sling Mesh Implants for Stress Incontinence.. 205. 2020
Active Surveillance for Men with Intermediate Risk Prostate Cancer.. 205. 2020
Correlates of 1-Year Change in Quality of Life in Patients with Urologic Chronic Pelvic Pain Syndrome: Findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.. 204. 2020
Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate.. 204. 2020
Comparison of Cancer Specific Outcomes following Minimally Invasive and Open Surgical Resection of Early Stage Kidney Cancer from a National Cancer Registry.. 203. 2020
Extraperitoneal versus Transperitoneal Single Port Robotic Radical Prostatectomy: A Comparative Analysis of Perioperative Outcomes.. 203. 2019
Sperm Genomic Integrity by TUNEL Varies throughout the Male Genital Tract.. 203. 2019
Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.. 203. 2019
Predictors of Psychosocial Distress in Parents of Young Children with Disorders of Sex Development.. 202. 2019
SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer.. 202. 2019
PTEN Loss with ERG Negative Status is Associated with Lethal Disease after Radical Prostatectomy.. 203. 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop.. 203. 2019
Variation in Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Outcomes in Asian American Men: A Multicenter Study.. 203. 2019
The Natural History and Composition of Urinary Catheter Biofilms: Early Uropathogen Colonization with Intraluminal and Distal Predominance.. 203. 2019
Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder: Focus on Safety and Cost.. 203. 2019
Association of Smoking and Death from Genitourinary Malignancies: Analysis of the National Longitudinal Mortality Study.. 202. 2019
Kidney Stones and Risk of Narcotic Use.. 202. 2019
The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer.. 202. 2019
Long-Term Implications of a Positive Posttreatment Biopsy in Patients Treated with External Beam Radiotherapy for Clinically Localized Prostate Cancer.. 201. 2019
Eliminating Early Surgery for Disorders of Sex Development: Risking Adverse Outcomes in 46, XX CAH.. 201. 2019
Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016.. 201. 2019
Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer.. 201. 2019
A Contemporary Analysis of Dual Inflatable Penile Prosthesis and Artificial Urinary Sphincter Outcomes.. 201. 2019
Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer.. 201. 2019
cT1a Renal Masses Less Than 2 versus 2 cm or Greater Managed by Robotic Partial Nephrectomy: A Propensity Score Matched Comparison of Perioperative Outcomes.. 201. 2019
Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness.. 200. 2018
Multiple Regions of Interest on Multiparametric Magnetic Resonance Imaging are Not Associated with Increased Detection of Clinically Significant Prostate Cancer on Fusion Biopsy.. 200. 2018
Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging.. 200. 2018
Correlates of Health Care Seeking Activities in Patients with Urological Chronic Pelvic Pain Syndromes: Findings from the MAPP Cohort.. 200. 2018
Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies.. 199. 2018
Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?. 199. 2018
A Case-Crossover Study of Urological Chronic Pelvic Pain Syndrome Flare Triggers in the MAPP Research Network.. 199. 2017
Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases.. 199. 2017
Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection.. 199. 2017
Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer.. 199. 2017
Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.. 199. 2017
Depressive Symptoms and Low Sexual Desire after Radical Prostatectomy: Early and Long-Term Outcomes in a Real-Life Setting.. 199. 2017
Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.. 199. 2017
Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer.. 199. 2017
Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.. 198. 2017
Predictors of Hospital Admission and Urological Intervention in Adult Emergency Department Patients with Computerized Tomography Confirmed Ureteral Stones.. 198. 2017
Contemporary Patterns of Care and Outcomes of Men Found to Have Lymph Node Metastases at the Time of Radical Prostatectomy.. 198. 2017
Clinical and Psychosocial Predictors of Urological Chronic Pelvic Pain Symptom Change in 1 Year: A Prospective Study from the MAPP Research Network.. 198. 2017
Psychological Adjustment of Parents of Children Born with Atypical Genitalia 1 Year after Genitoplasty.. 198. 2017
Percutaneous Management of Stone Containing Calyceal Diverticula: Associated Factors and Outcomes.. 198. 2017
Challenging the Myth: Transvaginal Mesh is Not Associated with Carcinogenesis.. 198. 2017
Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.. 198. 2017
Characterization of Whole Body Pain in Urological Chronic Pelvic Pain Syndrome at Baseline: A MAPP Research Network Study.. 198. 2017
Clinical Outcomes in Patients with Panurothelial Carcinoma Treated with Radical Nephroureterectomy Following Cystectomy for Metachronous Recurrence.. 198. 2017
Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.. 198. 2017
Resurfacing the Penis of Complex Hypospadias Repair ("Hypospadias Cripples").. 197. 2017
Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter Study.. 198. 2017
Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.. 197. 2016
Ultrasonographic Assessment of Testicular Viability Using Heterogeneity Levels in Torsed Testicles.. 197. 2016
Patient Function and the Value of Surgical Care for Kidney Cancer.. 197. 2016
Development and Validation of an Objective Scoring Tool for Robot-Assisted Radical Prostatectomy: Prostatectomy Assessment and Competency Evaluation.. 197. 2016
Indications, Utilization and Complications Following Prostate Biopsy: New York State Analysis.. 197. 2016
Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial.. 197. 2016
Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel.. 197. 2016
Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.. 197. 2016
Comparative Effectiveness of Cancer Control and Survival after Robot-Assisted versus Open Radical Prostatectomy.. 197. 2016
Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.. 197. 2016
Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.. 197. 2016
Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts.. 197. 2016
Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm.. 197. 2016
Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology.. 197. 2016
Retroperitoneal Lymph Node Dissection: Anatomical and Technical Considerations from a Cadaveric Study.. 196. 2016
Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States.. 196. 2016
Factors Impacting the Occurrence of Local, Distant and Atypical Recurrences after Robot-Assisted Radical Cystectomy: A Detailed Analysis of 310 Patients.. 196. 2016
External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC.. 196. 2016
Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.. 196. 2016
Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.. 196. 2016
Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate Biopsy.. 196. 2016
Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study.. 196. 2016
Life Expectancy and Variation in Treatment for Early Stage Kidney Cancer.. 196. 2016
Nerve Sparing Clitoroplasty is an Option for Adolescent and Adult Female Patients with Congenital Adrenal Hyperplasia and Clitoral Pain following Prior Clitoral Recession or Incomplete Reduction.. 195. 2016
The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.. 196. 2016
Erectile Function Recovery after Radical Prostatectomy in Men with High Risk Features.. 196. 2016
Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine.. 196. 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma.. 195. 2016
Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.. 196. 2015
Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.. 195. 2015
Multi-Institutional Experience with Robotic Nephrectomy with Inferior Vena Cava Tumor Thrombectomy.. 195. 2015
The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.. 195. 2015
Risk of Vascular Toxicity with Platinum Based Chemotherapy in Elderly Patients with Bladder Cancer.. 195. 2015
Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma.. 195. 2015
Characterizing Early Psychosocial Functioning of Parents of Children with Moderate to Severe Genital Ambiguity due to Disorders of Sex Development.. 194. 2015
Multi-Institutional Validation of Fundamental Inanimate Robotic Skills Tasks.. 194. 2015
Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance?. 195. 2015
Efficacy and Safety of Abiraterone Acetate in Elderly (75 Years or Older) Chemotherapy Naïve Patients with Metastatic Castration Resistant Prostate Cancer.. 194. 2015
Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active Surveillance.. 194. 2015
Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.. 194. 2015
Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma.. 194. 2015
Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.. 194. 2015
The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer Landscape.. 194. 2015
Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.. 193. 2014
Comparison of baseline urological symptoms in men and women in the MAPP research cohort.. 193. 2014
Renal cell carcinoma in children, adolescents and young adults: a National Cancer Database study.. 193. 2014
Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP study.. 193. 2014
A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomy.. 193. 2014
Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.. 193. 2014
Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.. 193. 2014
Usefulness of transurethral biopsy for staging the prostatic urethra before radical cystectomy.. 193. 2014
Robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients.. 192. 2014
Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failure.. 192. 2014
Risk of chronic and end stage kidney disease in patients with nephrolithiasis.. 192. 2014
Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.. 192. 2014
Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology.. 192. 2014
Functional magnetic resonance imaging during urodynamic testing identifies brain structures initiating micturition.. 192. 2014
Resource utilization and costs associated with the diagnostic evaluation of nonrefluxing primary hydronephrosis in infants.. 192. 2014
Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening.. 192. 2014
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.. 192. 2014
Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer.. 192. 2014
Clinical outcomes of local and metastatic testicular sex cord-stromal tumors.. 192. 2014
Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.. 192. 2014
Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?. 192. 2014
Use of a preoperative checklist reduces risk of penile prosthesis infection.. 192. 2013
Risk factors for the development of parastomal hernia after radical cystectomy.. 191. 2013
The prevalence of persistent prostate cancer after radiotherapy detected at radical cystoprostatectomy for bladder cancer.. 191. 2013
Inflammatory response to Escherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host.. 191. 2013
The association between statin medication and progression after surgery for localized renal cell carcinoma.. 191. 2013
Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery.. 191. 2013
Changes in pelvic organ prolapse surgery in the last decade among United States urologists.. 191. 2013
A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy.. 191. 2013
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.. 191. 2013
Relationship between C-reactive protein and kidney stone prevalence.. 191. 2013
Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer.. 191. 2013
The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance.. 191. 2013
Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer.. 191. 2013
Severe testicular atrophy does not affect the success of microdissection testicular sperm extraction.. 191. 2013
Use of surveillance imaging following treatment of small renal masses.. 190. 2013
Image based feasibility of renal sparing surgery for very low risk unilateral Wilms tumors: a report from the Children's Oncology Group.. 190. 2013
Risk of incisional hernia after minimally invasive and open radical prostatectomy.. 190. 2013
Perioperative celecoxib decreases opioid use in patients undergoing testicular surgery: a randomized, double-blind, placebo controlled trial.. 190. 2013
Functional status and postoperative morbidity in older women with prolapse.. 190. 2013
Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists.. 190. 2013
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy.. 190. 2013
Urine neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after kidney surgery.. 190. 2013
A multi-institutional evaluation of active surveillance for low risk prostate cancer.. 189. 2013
A comparison of models for predicting sperm retrieval before microdissection testicular sperm extraction in men with nonobstructive azoospermia.. 189. 2012
Localization of sperm during microdissection testicular sperm extraction in men with nonobstructive azoospermia.. 189. 2012
Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States.. 189. 2012
Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.. 189. 2012
Clinically significant prostate cancer is rarely missed by ablative procedures of the prostate in men with prostate specific antigen less than 4 ng/ml.. 189. 2012
Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device.. 189. 2012
Influence of surgeon and hospital volume on radical prostatectomy costs.. 188. 2012
Improvement in overall survival of patients with advanced renal cell carcinoma: prognostic factor trend analysis from an international data set of clinical trials.. 188. 2012
Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade.. 189. 2012
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer.. 188. 2012
Transperineal management for postoperative and radiation rectourethral fistulas.. 189. 2012
How dry is "OAB-dry"? Perspectives from patients and physician experts.. 188. 2012
Long-term durability of the distal urethral polypropylene sling for the treatment of stress urinary incontinence: minimum 11-year followup.. 188. 2012
Stepwise description and outcomes of bladder neck sparing during robot-assisted laparoscopic radical prostatectomy.. 188. 2012
Factors associated with the adoption of minimally invasive radical prostatectomy in the United States.. 188. 2012
Role of optimizing testosterone before microdissection testicular sperm extraction in men with nonobstructive azoospermia.. 188. 2012
Surgical practice patterns for male urinary incontinence: analysis of case logs from certifying American urologists.. 188. 2012
Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States.. 187. 2012
Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series.. 187. 2012
Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality.. 187. 2012
Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy.. 187. 2012
Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery.. 187. 2012
Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy.. 187. 2012
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.. 187. 2012
Recovery of urinary function after radical prostatectomy: predictors of urinary function on preoperative prostate magnetic resonance imaging.. 187. 2012
Zero ischemia anatomical partial nephrectomy: a novel approach.. 187. 2012
Global evaluative assessment of robotic skills: validation of a clinical assessment tool to measure robotic surgical skills.. 187. 2011
Surgical innovation and outcome measures for male urethral surgery.. 186. 2011
Amelioration of renal ischemia-reperfusion injury with a novel protective cocktail.. 186. 2011
Identification of spermatogenesis with multiphoton microscopy: an evaluation in a rodent model.. 186. 2011
Laparoendoscopic single site live donor nephrectomy: single institution report of initial 100 cases.. 186. 2011
Comparison of complications of laparoscopic versus laparoendoscopic single site donor nephrectomy using the modified Clavien grading system.. 186. 2011
Comparison of outpatient narcotic prescribing patterns after minimally invasive versus retropubic and perineal radical prostatectomy.. 186. 2011
17α-Estradiol and genistein inhibit high fat diet induced prostate gene expression and prostate growth in the rat.. 186. 2011
Use of empiric antibiotics in the setting of an increased prostate specific antigen: con.. 186. 2011
Routine drain placement after partial nephrectomy is not always necessary.. 186. 2011
Use of empiric antibiotics in the setting of an increased prostate specific antigen: pro.. 186. 2011
Cold intravascular organ perfusion for renal hypothermia during laparoscopic partial nephrectomy.. 185. 2011
Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy.. 185. 2011
Selective arterial embolization for pseudoaneurysms and arteriovenous fistula of renal artery branches following partial nephrectomy.. 185. 2011
Molecular effects of genistein on male urethral development.. 185. 2011
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).. 185. 2011
Overuse of imaging for staging low risk prostate cancer.. 185. 2011
Duration of microdissection testicular sperm extraction procedures: relationship to sperm retrieval success.. 185. 2011
Intraoperative conversion from partial to radical nephrectomy at a single institution from 2003 to 2008.. 185. 2011
Successful repeat microdissection testicular sperm extraction in men with nonobstructive azoospermia.. 185. 2011
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.. 185. 2011
Renal oncocytosis: management and clinical outcomes.. 185. 2011
Inhibition of aberrant androgen receptor induction of prostate specific antigen gene expression, cell proliferation and tumor growth by 17α-estradiol in prostate cancer.. 185. 2011
Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma.. 185. 2010
Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function.. 185. 2010
Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer.. 185. 2010
Diagnosis of the gr/gr Y chromosome microdeletion does not help in the treatment of infertile American men.. 185. 2010
Chronic kidney disease before and after partial nephrectomy.. 185. 2010
Comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy.. 185. 2010
Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases.. 185. 2010
Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials.. 185. 2010
An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy.. 184. 2010
The learning curve for laparoscopic radical prostatectomy: an international multicenter study.. 184. 2010
Laparoendoscopic single site live donor nephrectomy: initial experience.. 184. 2010
Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy.. 184. 2010
Gating of sensory information differs in patients with interstitial cystitis/painful bladder syndrome.. 184. 2010
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.. 184. 2010
Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.. 184. 2010
Impact of prior prostate radiation on complications after radical prostatectomy.. 184. 2010
Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy.. 184. 2010
Outcomes of laparoscopic donor nephrectomy without intraoperative systemic heparinization.. 183. 2010
Urethral diverticula in women: discrepancies between magnetic resonance imaging and surgical findings.. 183. 2010
Complications after radical and partial nephrectomy as a function of age.. 183. 2010
Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes.. 183. 2010
Decreasing electrosurgical transurethral resection of the prostate surgical volume during graduate medical education training is associated with increased surgical adverse events.. 183. 2010
How do you tell whether a change in surgical technique leads to a change in outcome?. 183. 2010
Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.. 183. 2010
Small incidentally discovered testicular masses in infertile men--is active surveillance the new standard of care?. 183. 2010
The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point.. 183. 2010
Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates.. 183. 2010
Variations among experienced surgeons in cancer control after open radical prostatectomy.. 183. 2010
Renal insufficiency is an independent risk factor for complications after partial nephrectomy.. 183. 2010
Low annual caseloads of United States surgeons conducting radical prostatectomy.. 182. 2009
Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors.. 182. 2009
Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma.. 182. 2009
Ureteroileocecal appendicostomy based urinary reservoir in irradiated and nonirradiated patients.. 182. 2009
Validating the incontinence symptom severity index: a self-assessment instrument for voiding symptom severity in women.. 182. 2009
Clinical presentation and urachal remnant pathology: implications for treatment.. 182. 2009
Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer.. 182. 2009
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.. 182. 2009
Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.. 182. 2009
Successful fertility treatment for Klinefelter's syndrome.. 182. 2009
Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical prostatectomy.. 182. 2009
Metastatic renal cell carcinoma risk according to tumor size.. 182. 2009
Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.. 181. 2009
Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat.. 181. 2009
Tumor size is associated with malignant potential in renal cell carcinoma cases.. 181. 2009
A multi-institutional evaluation of active surveillance for low risk prostate cancer.. 181. 2009
S1P/S1P2 signaling induces cyclooxygenase-2 expression in Wilms tumor.. 181. 2009
Contemporary use of partial nephrectomy at a tertiary care center in the United States.. 181. 2009
Surgical apgar outcome score: perioperative risk assessment for radical cystectomy.. 181. 2009
Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria.. 181. 2008
Antagonism of BMP4 signaling disrupts smooth muscle investment of the ureter and ureteropelvic junction.. 181. 2008
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?. 181. 2008
Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study.. 180. 2008
Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.. 180. 2008
Patterns of care for radical prostatectomy in the United States from 2003 to 2005.. 180. 2008
Renal cell carcinoma in young and old patients--is there a difference?. 180. 2008
Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma.. 180. 2008
The effect of concomitant prolapse repair on sling outcomes.. 180. 2008
The outcome of intracytoplasmic sperm injection using occasional spermatozoa in the ejaculate of men with spermatogenic failure.. 180. 2008
Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.. 180. 2008
Incidental testicular lesions found during infertility evaluation are usually benign and may be managed conservatively.. 180. 2008
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.. 179. 2008
Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.. 179. 2008
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.. 179. 2008
Preoperative nomogram predicting 12-year probability of metastatic renal cancer.. 179. 2008
Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.. 179. 2008
Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005.. 179. 2008
Establishing the prevalence of incontinence study: racial differences in women's patterns of urinary incontinence.. 179. 2008
Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer.. 179. 2008
Sexual function and quality of life in the male partner of infertile couples: prevalence and correlates of dysfunction.. 179. 2008
The pathophysiology of large capacity bladder.. 179. 2008
Revision washout decreases implant capsule tissue culture positivity: a multicenter study.. 179. 2007
Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.. 179. 2007
A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer.. 178. 2007
Elisabeth Pauline Pickett (1918-): opening the door for women in urological oncology.. 178. 2007
Sunitinib efficacy against advanced renal cell carcinoma.. 178. 2007
Urogenital disorders associated with gut failure and intestinal transplantation.. 178. 2007
Nerve sparing ventral clitoroplasty preserves dorsal nerves in congenital adrenal hyperplasia.. 178. 2007
Association of procedure volume with radical cystectomy outcomes in a nationwide database.. 178. 2007
Esthetic outcomes of genitoplasty in males born with bladder exstrophy and epispadias.. 178. 2007
Nerve sparing ventral clitoroplasty: analysis of clitoral sensitivity and viability.. 178. 2007
The role of preoperative testing on outcomes after sling surgery for stress urinary incontinence.. 178. 2007
Variations in stress incontinence and prolapse management by surgeon specialty.. 178. 2007
Management of low grade papillary bladder tumors.. 178. 2007
Castration resistant, taxane naïve metastatic prostate cancer: current clinical approaches and future directions.. 178. 2007
Uniform testicular maturation arrest: a unique subset of men with nonobstructive azoospermia.. 178. 2007
Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.. 178. 2007
Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.. 178. 2007
A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization.. 177. 2007
Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.. 177. 2007
Bilateral caudal epidural neuromodulation for refractory urinary retention: a salvage procedure.. 177. 2007
Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.. 177. 2007
Is sildenafil citrate associated with an amelioration of the symptomatology of androgen decline in the aging male?. 177. 2007
Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors.. 177. 2007
Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.. 178. 2007
Urachal carcinoma: contemporary surgical outcomes.. 178. 2007
Racial disparities in the surgical management of stress incontinence among female Medicare beneficiaries.. 177. 2007
Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.. 177. 2007
Interferon-alpha resistance associated genes in renal cell carcinoma identified by expression profiling.. 177. 2007
Microdissection testicular sperm extraction: effect of prior biopsy on success of sperm retrieval.. 177. 2007
The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies.. 177. 2007
The role of provider volume on outcomes after sling surgery for stress urinary incontinence.. 177. 2007
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.. 177. 2007
13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine.. 177. 2007
Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.. 177. 2007
Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach.. 177. 2007
Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience.. 177. 2007
Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development.. 177. 2007
The anterior layer of Denonvilliers' fascia: a common misconception in the laparoscopic prostatectomy literature.. 177. 2007
Bladder necrosis following hydrodistention in patients with interstitial cystitis.. 177. 2007
Predicting the histology of renal masses using preoperative Doppler ultrasonography.. 177. 2007
The natural progression and remission of erectile dysfunction: results from the Massachusetts Male Aging Study.. 177. 2007
Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex.. 176. 2006
Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study.. 176. 2006
Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.. 176. 2006
Adult genitourinary sarcoma: the 25-year Memorial Sloan-Kettering experience.. 176. 2006
Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis.. 176. 2006
Natural history of positive urinary cytology after radical cystectomy.. 176. 2006
Percutaneous computerized tomography guided cryoablation for localized renal cell carcinoma: factors influencing success.. 176. 2006
The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination survey.. 176. 2006
Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma.. 176. 2006
Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway.. 176. 2006
Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function.. 176. 2006
Erectile dysfunction--an observable marker of diabetes mellitus? A large national epidemiological study.. 176. 2006
Percutaneous computerized tomography guided renal cryoablation using local anesthesia: pain assessment.. 176. 2006
Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading.. 176. 2006
Protective effects of plasma carotenoids on the risk of bladder cancer.. 176. 2006
Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction.. 176. 2006
Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.. 176. 2006
Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings.. 176. 2006
Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study.. 176. 2006
Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.. 176. 2006
Prior circumcision does not complicate repair of hypospadias with an intact prepuce.. 176. 2006
An analysis of the natural history of Peyronie's disease.. 175. 2006
Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract.. 175. 2006
Failure of sacral nerve stimulation due to migration of tined lead.. 175. 2006
Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins.. 175. 2006
Sexual function following bowel vaginoplasty.. 175. 2006
Spiral sling salvage anti-incontinence surgery in female patients with a nonfunctional urethra: technique and initial results.. 175. 2006
Efficacy and safety of histrelin subdermal implant in patients with advanced prostate cancer.. 175. 2006
The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.. 175. 2006
Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.. 175. 2006
Biological correlates of p27 compartmental expression in prostate cancer.. 175. 2006
Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience.. 175. 2006
Long-term durability of the distal urethral polypropylene sling procedure for stress urinary incontinence: minimum 5-year followup of surgical outcome and satisfaction determined by patient reported questionnaires.. 175. 2006
Perioperative complications of laparoscopic and robotic assisted laparoscopic radical prostatectomy.. 175. 2006
Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.. 175. 2006
Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner.. 175. 2006
Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.. 174. 2005
Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996-2000.. 174. 2005
Kidney paired donation and optimizing the use of live donor organs.. 174. 2005
Processed lipoaspirate cells for tissue engineering of the lower urinary tract: implications for the treatment of stress urinary incontinence and bladder reconstruction.. 174. 2005
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.. 174. 2005
Quality of care: partial cystectomy for bladder cancer--a case of inappropriate use?. 174. 2005
Radiation exposure and the urologist: what are the risks?. 174. 2005
Anatomy of accessory pudendal arteries in laparoscopic radical prostatectomy.. 174. 2005
Health issues of men: prevalence and correlates of erectile dysfunction.. 174. 2005
Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma.. 174. 2005
Outcome and late failures compared in 4 techniques of microsurgical vasoepididymostomy in 153 consecutive men.. 174. 2005
Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup.. 174. 2005
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.. 174. 2005
Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: experience in 107 patients.. 174. 2005
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.. 173. 2005
Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.. 173. 2005
Ethnic background has minimal impact on the etiology of nephrolithiasis.. 173. 2005
Testosterone as a predictor of pathological stage in clinically localized prostate cancer.. 173. 2005
The natural history of chronic allograft nephropathy.. 173. 2005
Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.. 173. 2005
Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer.. 173. 2005
No-needle jet anesthetic technique for no-scalpel vasectomy.. 173. 2005
Quality improvement in laparoscopic radical prostatectomy for pT2 prostate cancer: impact of video documentation review on positive surgical margin.. 173. 2005
Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.. 173. 2005
A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.. 173. 2005
Revision washout decreases penile prosthesis infection in revision surgery: a multicenter study.. 173. 2005
c-kit and ureteral peristalsis.. 173. 2005
Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy.. 172. 2004
Pathophysiology of unilateral ureteral obstruction: studies from Charlottesville to New York.. 172. 2004
Results of 265 consecutive proximal hypospadias repairs using the Thiersch-Duplay principle.. 172. 2004
Race is not a predictor of prostate cancer detection on repeat prostate biopsy.. 172. 2004
Efficacy of continuous epidural analgesia versus single dose caudal analgesia in children after intravesical ureteroneocystostomy.. 172. 2004
Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis.. 172. 2004
Bicycle riding and its relationship to the development of erectile dysfunction.. 172. 2004
Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review.. 172. 2004
Toward a sutureless vasovasostomy: use of biomaterials and surgical sealants in a rodent vasovasostomy model.. 172. 2004
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. 172. 2004
Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.. 172. 2004
When can persistent hydroureteronephrosis in posterior urethral valve disease be considered residual stretching?. 172. 2004
Does Valsalva leak point pressure predict outcome after the distal urethral polypropylene sling? Role of urodynamics in the sling era.. 172. 2004
Hand assisted laparoscopic training for postgraduate urologists: the role of mentoring.. 172. 2004
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.. 172. 2004
Radio frequency ablation of small renal tumors:: intermediate results.. 171. 2004
An analysis of men with clinically localized prostate cancer who deferred definitive therapy.. 171. 2004
Impact of unnecessary exploratory laparotomy on the treatment of patients with metastatic germ cell tumor.. 171. 2004
Robotic microsurgical vasovasostomy and vasoepididymostomy: a prospective randomized study in a rat model.. 171. 2004
Ketorolac: safe and effective analgesia for the management of renal cortical tumors with partial nephrectomy.. 171. 2004
Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology.. 171. 2004
Dietary L-arginine supplementation improves the glomerular filtration rate and renal blood flow after 24 hours of unilateral ureteral obstruction in rats.. 171. 2004
Do concerns about more advanced pathological features increase the likelihood of neurovascular bundle resection in black men undergoing radical prostatectomy?. 171. 2004
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.. 171. 2004
Is year of radical prostatectomy a predictor of outcome in prostate cancer?. 171. 2004
Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival.. 171. 2004
Predicting quality of life after radical prostatectomy: results from CaPSURE.. 171. 2004
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.. 171. 2004
Complications of radical and partial nephrectomy in a large contemporary cohort.. 171. 2004
Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.. 171. 2004
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.. 170. 2003
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.. 170. 2003
Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.. 170. 2003
Postmortem sperm retrieval: the effect of instituting guidelines.. 170. 2003
Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen.. 170. 2003
A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session.. 170. 2003
A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results.. 170. 2003
Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging.. 170. 2003
Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors.. 170. 2003
Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis.. 170. 2003
Testicular sperm extraction with intracytoplasmic sperm injection is successful for the treatment of nonobstructive azoospermia associated with cryptorchidism.. 170. 2003
Prospective analysis of patients treated with a distal urethral polypropylene sling for symptoms of stress urinary incontinence: surgical outcome and satisfaction determined by patient driven questionnaires.. 170. 2003
Radical prostatectomy nomograms in black American men: accuracy and applicability.. 170. 2003
Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001.. 169. 2003
Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy.. 169. 2003
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.. 169. 2003
Regret in men treated for localized prostate cancer.. 169. 2003
Inducible nitric oxide synthase promotes pathophysiological consequences of experimental bladder outlet obstruction.. 169. 2003
Temporal trends in radical prostatectomy complications from 1991 to 1998.. 169. 2003
Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?. 169. 2003
Ten-year experience with transvaginal vesicovaginal fistula repair using tissue interposition.. 169. 2003
Effect of hormonal manipulation on mRNA expression of antioxidant enzymes in the rat testis.. 169. 2003
Pleural injury during laparoscopic renal surgery: early recognition and management.. 169. 2003
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.. 168. 2002
Men with nonobstructive azoospermia have Leydig cell hypertrophy but not hyperplasia.. 168. 2002
Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging.. 168. 2002
High intensity focused ultrasound ablation of the vas deferens in a canine model.. 167. 2002
Cross-linked matrix tissue sealant protects against mortality and hemorrhage in an acute renal injury model in heparinized rats.. 167. 2002
Treatment of chronic prostatitis lowers serum prostate specific antigen.. 167. 2002
Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.. 167. 2002
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.. 167. 2002
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.. 167. 2002
Aromatase inhibitors for male infertility.. 167. 2002
Cancer control with radical prostatectomy alone in 1,000 consecutive patients.. 167. 2002
Diethylstilbesterol revisited: androgen deprivation, osteoporosis and prostate cancer.. 167. 2002
Evaluation of octylcyanoacrylate for wound repair of clinical circumcision and human skin incisional healing in a nude rat model.. 167. 2002
Paracolic recurrence: the importance of wide excision of the spermatic cord at retroperitoneal lymph node dissection.. 167. 2002
Fibroblast growth factor-7 regulates stratification of the bladder urothelium.. 166. 2001
Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.. 166. 2001
Improvement in emotional well-being and relationships of users of sildenafil.. 166. 2001
Pressure flow measurement of hydronephrosis in children: a new approach to definition and quantification of obstruction.. 166. 2001
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.. 166. 2001
Magnetic resonance imaging for the evaluation of hydronephrosis, reflux and renal scarring in children.. 166. 2001
Aging effects on contractility of longitudinal and circular detrusor and trigone of rat bladder.. 166. 2001
A postoperative prognostic nomogram for renal cell carcinoma.. 166. 2001
Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup.. 165. 2001
Pubovaginal sling using cadaveric fascia and bone anchors: disappointing early results.. 165. 2001
Cystectomy for bladder cancer: a contemporary series.. 165. 2001
Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance.. 165. 2001
Evaluation of sonographic renal parenchymal area in the management of hydronephrosis.. 165. 2001
Tensile strength of cadaveric fascia lata compared to small intestinal submucosa using suture pull through analysis.. 165. 2001
Mechanism of healing following the Snodgrass repair.. 165. 2001
Factors predicting recovery of erections after radical prostatectomy.. 164. 2000
Interaction of nitric oxide and transforming growth factor-beta1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells.. 164. 2000
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.. 164. 2000
1999 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care.. 164. 2000
Cytokine variations in patients with hormone treated prostate cancer.. 164. 2000
Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.. 164. 2000
Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.. 164. 2000
Urodynamics in spinal cord injured patients walking with reciprocating gait orthosis.. 164. 2000
BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation.. 163. 2000
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.. 163. 2000
A clinical series of laparoscopic nephrectomy, nephroureterectomy and heminephroureterectomy in the pediatric population.. 163. 2000
The plug and patch: a new technique for repair of corporal perforation during placement of penile prostheses.. 163. 2000
An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.. 163. 2000
Surgical management of renal tumors 4 cm. or less in a contemporary cohort.. 163. 2000
Assessment of the degradation of denatured albumin solder by human urine.. 163. 2000
Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.. 163. 2000
The dispute about the external sphincter and the urogenital diaphragm.. 162. 1999
1998 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of ureteral stones and impact of managed care.. 162. 1999
Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversion.. 162. 1999
Sildenafil citrate after radical retropubic prostatectomy.. 162. 1999
Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation.. 162. 1999
Immune response in patients with persistent candiduria and occult candidemia.. 162. 1999
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.. 162. 1999
Prognostic factors for long-term renal function in boys with the prune-belly syndrome.. 162. 1999
Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model.. 162. 1999
Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma.. 162. 1999
BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy.. 162. 1999
Comparison of bilateral versus unilateral varicocelectomy in men with palpable bilateral varicoceles.. 162. 1999
Helical computerized tomography arteriography for evaluation of live renal donors undergoing laparoscopic nephrectomy.. 162. 1999
Function of M3 muscarinic receptors in the rat urinary bladder following partial outlet obstruction.. 161. 1999
The effects of mesh bioprosthesis on the spermatic cord structures: a preliminary report in a canine model.. 161. 1999
Preperitoneal prosthetic mesh hernioplasty during radical retropubic prostatectomy.. 161. 1999
Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology.. 161. 1999
Can p53 help select patients with invasive bladder cancer for bladder preservation?. 161. 1999
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.. 161. 1999
Real-time transesophageal echocardiography for intraoperative surveillance of patients with renal cell carcinoma and vena caval extension undergoing radical nephrectomy.. 161. 1999
1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997.. 160. 1998
Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary?. 160. 1998
Multiple primary malignancies in renal cell carcinoma.. 160. 1998
Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen: long-term followup.. 160. 1998
A serous lined antireflux valve: in vivo fluorourodynamic evaluation of antireflux continence mechanism.. 160. 1998
Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure.. 160. 1998
Evaluation of new resectoscope loop for transurethral resection of bladder tumors.. 159. 1998
The T pouch: an orthotopic ileal neobladder incorporating a serosal lined ileal antireflux technique.. 159. 1998
Clinical stage I testis cancer: long-term outcome of patients on surveillance.. 159. 1998
Low p27 expression predicts poor disease-free survival in patients with prostate cancer.. 159. 1998
The use of bladder for total transplant ureteral reconstruction.. 159. 1998
The value of unenhanced helical computerized tomography in the management of acute flank pain.. 159. 1998
Subspecialization, recruitment and retirement trends of American urologists.. 159. 1998
Influence of hepatic function on serum levels of prostate specific antigen.. 158. 1997
A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer.. 158. 1997
Transrectal prostate ultrasonography: variability of interpretation.. 158. 1997
Cu/Zn superoxide dismutase, catalase and glutathione peroxidase mRNA expression in the rat testis after surgical cryptorchidism and efferent duct ligation.. 158. 1997
Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?. 157. 1997
Immunostimulatory therapy with anti-CD3 monoclonal antibodies and recombinant interleukin-2: heightened in vivo expression of mRNA encoding cytotoxic attack molecules and immunoregulatory cytokines and regression of murine renal cell carcinoma.. 157. 1997
Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.. 157. 1997
Molecular staging of prostate cancer. III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay.. 157. 1997
Comparison of fibrin glue, laser weld, and mechanical suturing device for the laparoscopic closure of ureterotomy in a porcine model.. 157. 1997
Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial.. 157. 1997
Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue.. 157. 1997
Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actions.. 156. 1996
Electromotive drug administration to the urinary bladder: an animal model and preliminary results.. 156. 1996
Telesurgical consultation.. 156. 1996
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.. 156. 1996
Use of an anti-ras ribozyme to alter the malignant phenotype of a human bladder cancer cell line.. 156. 1996
Human cytomegalovirus is not implicated in benign prostatic hyperplasia: a study using immunohistochemistry and the polymerase chain reaction.. 156. 1996
Early identification of candiduria by polymerase chain reaction in high risk patients.. 156. 1996
Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis.. 156. 1996
Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes.. 155. 1996
Laparoscopic orchiopexy: clinical experience and description of technique.. 155. 1996
Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.. 155. 1996
Radical retropubic prostatectomy: limited benefit of autologous blood donation.. 154. 1995
A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.. 154. 1995
Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced bladder cancer overview collaboration.. 154. 1995
Prognostic significance of positive surgical margins in radical prostatectomy specimens.. 154. 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.. 154. 1995
Pelvic lymph node histiocytosis mimicking metastatic prostatic adenocarcinoma: association with hip prostheses.. 154. 1995
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer.. 154. 1995
LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of BCG therapy.. 154. 1995
Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.. 154. 1995
A simple ileal substitute bladder after radical cystectomy: experience with a modification of the Studer pouch.. 153. 1995
TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49.. 153. 1995
Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction.. 153. 1995
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5 year follow-up.. 153. 1995
Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.. 153. 1995
Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues.. 152. 1994
Neurotrophic factors in the rat penis.. 152. 1994
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.. 152. 1994
A critique of the decision analysis for clinically localized prostate cancer.. 152. 1994
Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer.. 152. 1994
An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma.. 152. 1994
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?. 152. 1994
Problem of prostate cancer.. 152. 1994
The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer.. 152. 1994
The pathological features and prognosis of prostate cancer detectable with current diagnostic tests.. 152. 1994
Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study.. 152. 1994
A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer.. 152. 1994
Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.. 152. 1994
Development and initial application of a real time thermal control system for laser tissue welding.. 152. 1994
High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.. 152. 1994
The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy.. 152. 1994
Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer.. 151. 1994
Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis.. 151. 1994
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.. 151. 1994
Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma.. 151. 1994
Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features.. 151. 1994
Myocutaneous flaps in genitourinary oncology.. 151. 1994
Neuroendocrine differentiation in metastatic prostatic adenocarcinoma.. 151. 1994
Impotence and chronic renal failure: a study of the hemodynamic pathophysiology.. 151. 1994
Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma.. 150. 1993
Urological evaluation and management of renal-proximity stab wounds.. 150. 1993
Possible mechanism for seeding of tumor during radical prostatectomy.. 150. 1993
Chromophore enhanced laser welding of canine ureters in vitro using a human protein solder: a preliminary step for laparoscopic tissue welding.. 150. 1993
Effect of atrial natriuretic peptide on urine flow and glomerular filtration during acute renal allograft rejection.. 150. 1993
Patch graft urethroplasty using dye enhanced laser tissue welding with a human protein solder: a preclinical canine model.. 150. 1993
Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors.. 150. 1993
The development of tumors in experimental gastroenterocystoplasty.. 150. 1993
Transdermal dihydrotestosterone therapy and its effects on patients with microphallus.. 150. 1993
Posttraumatic impotence: magnetic resonance imaging and duplex ultrasound in diagnosis and management.. 149. 1993
Studies of the hormonal control of postnatal testicular descent in the rat.. 149. 1993
Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors.. 148. 1992
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.. 148. 1992
Magnetic resonance imaging of traumatic posterior urethral defects and pelvic crush injuries.. 148. 1992
Angiographic embolization of renal stab wounds.. 148. 1992
Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens.. 148. 1992
Radiographic evaluation of adult patients with blunt renal trauma.. 148. 1992
Optimal parameters for CO2 laser reconstruction of urethral tissue using a protein solder.. 148. 1992
Prostatic and periprostatic interstitial temperature measurements in patients treated with transrectal thermal therapy (local intracavitary microwave hyperthermia).. 147. 1992
The clinical effects of a 5 alpha-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group.. 147. 1992
Adult urological sarcoma.. 147. 1992
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer.. 147. 1992
Detection and staging of prostatic carcinoma after transurethral resection or open enucleation of the prostate: accuracy of magnetic resonance imaging.. 147. 1992
Detection of human papillomavirus in squamous neoplasm of the penis.. 147. 1992
The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer.. 146. 1991
DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder.. 146. 1991
A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate.. 146. 1991
The risk of dying of prostate cancer in patients with clinically localized disease.. 146. 1991
Transrectal ultrasonography in stage A prostate cancer: detection of residual tumor after transurethral resection of prostate.. 146. 1991
An improved method for computerized tomography-planned transperineal 125iodine prostate implants.. 146. 1991
Subclinical varicocele: the effectiveness of varicocelectomy.. 145. 1991
The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer.. 145. 1991
Technique of left adrenalectomy for autotransplantation to the caudate nucleus in Parkinson's disease.. 144. 1990
125iodine reimplantation for locally progressive prostatic carcinoma.. 144. 1990
Urethrectomy with preservation of potency.. 144. 1990
Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.. 144. 1990
Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation.. 143. 1990
Infrequent ras oncogene point mutations in renal cell carcinoma.. 143. 1990
Urethral reconstruction using the carbon dioxide laser: an experimental evaluation.. 142. 1989
The urological manifestations of the acquired immunodeficiency syndrome.. 142. 1989
Prognostic significance of lymph nodal metastases in prostate cancer.. 142. 1989
The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer.. 142. 1989
Risk factors for perineal seeding of prostate cancer after needle biopsy.. 142. 1989
The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations.. 142. 1989
Candidal antigenemia: a prognostic determinant.. 141. 1989
Characterization and localization of in vivo phospholipid methylation in the hamster testis.. 141. 1989
Detection of testicular endocrine abnormalities and their correlation with serum antisperm antibodies in men following vasectomy.. 141. 1989
Cytotoxicity of high energy shock waves: methodologic considerations.. 141. 1989
Neuroanatomy of the pelvis in an infant with cloacal exstrophy: a detailed microdissection with histology.. 141. 1989
Primary signet ring cell adenocarcinoma of the bladder.. 141. 1989
Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin).. 140. 1988
Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate.. 140. 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.. 139. 1988
Laser welding in urethral surgery: improved results with a protein solder.. 139. 1988
Free radical production by high energy shock waves--comparison with ionizing irradiation.. 139. 1988
Miconazole: a cost-effective antifungal genitourinary irrigant.. 138. 1987
Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function.. 138. 1987
Initial experience with extracorporeal shock wave lithotripsy in children.. 138. 1987
Magnetic resonance imaging in genital anomalies.. 138. 1987
Identification of "tumor-associated" nucleolar antigens in human urothelial cancer.. 138. 1987
Development and characterization of a monoclonal antibody to human embryonal carcinoma.. 137. 1987
Simultaneous preperitoneal hernia repair during radical pelvic surgery.. 137. 1987
The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction.. 137. 1987
Histopathologic and ultrastructural correlates of tumor growth suppression by high energy shock waves.. 137. 1987
Assessment of clinical renal preservation by phosphorus-31 magnetic resonance spectroscopy.. 137. 1987
Assessment of renal preservation by phosphorus-31 magnetic resonance spectroscopy: in vivo normothermic blood perfusion.. 136. 1986
Effect of thromboxane inhibition on renal blood flow in dogs with complete unilateral ureteral obstruction.. 136. 1986
Predictors of eventual end stage renal disease in children with posterior urethral valves.. 136. 1986
The prevalence of 5 alpha-reductase deficiency in children with ambiguous genitalia in the Dominican Republic.. 136. 1986
Sertoli cell production of müllerian inhibiting substance in vitro.. 136. 1986
Assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy.. 135. 1986
Scrotal ultrasound in the infertile man: detection of subclinical unilateral and bilateral varicoceles.. 135. 1986
Functional evaluation of penile veins by cavernosography in papaverine-induced erection.. 135. 1986
High energy shock waves suppress tumor growth in vitro and in vivo.. 135. 1986
The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer.. 135. 1986
The effect of graded unilateral testicular biopsy on the reproductive capacity of male rats.. 135. 1986
Human renal cell carcinoma xenograft: morphology, growth and chemosensitivities.. 134. 1985
Urolithiasis and race: another viewpoint.. 134. 1985
Renal trauma: evaluation by computerized tomography.. 133. 1985
Transrectal ultrasonography for prostatic cancer: its value in staging and monitoring the response to radiotherapy and chemotherapy.. 133. 1985
Vinblastine and methotrexate for advanced bladder cancer.. 133. 1985
Immunohistologic dissection of the human kidney using monoclonal antibodies.. 133. 1985
Selective pre-transplant nephrectomy: indications and perioperative management.. 133. 1985
Do the imidazoles have a role in the management of genitourinary fungal infections?. 133. 1985
Phase II trial of doxorubicin in bidimensionally measurable prostatic adenocarcinoma.. 131. 1984
Prophylactic antibiotics and Foley catheter use in transperineal needle biopsy of the prostate.. 131. 1984
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer.. 129. 1983
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area.. 129. 1983
Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney.. 129. 1983
Amphotericin B as a urologic irrigant in the management of noninvasive candiduria.. 128. 1982
A nosocomial epidemic of antibiotic-resistant Serratia marcescens urinary tract infections.. 124. 1980
Flucytosine in the management of genitourinary candidiasis: 5 years of experience.. 124. 1980
Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.. 123. 1980
Fertility problems in the renal transplant patient.. 118. 1977
The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.. 118. 1977
Ureterosigmoidostomy.. 118. 1977
Genitourinary candidiasis: diagnosis and treatment.. 116. 1976
Family study of vesicoureteral reflux.. 113. 1975
Injuries associated with renal trauma.. 109. 1973
Transient significant bacteriuria in women.. 109. 1973
The serodiagnosis of significant genitourinary candidiasis.. 107. 1972
Evidence against a vesicorenal reflex.. 107. 1972
Urinary retention associated with herpes zoster.. 104. 1970
Tissue culture of human renal cell carcinoma: effect of serum on monolayer growth.. 103. 1970
Panel discussion: medicolegal aspects of urology.. 81. 1959
Editorial Comment.. 206. 2021
Editorial Comment.. 204. 2020
Editorial Comment.. 203. 2020
Editorial Comment.. 203. 2019
Editorial Comment.. 202. 2019
Editorial Comment.. 199. 2017
Editorial Comment.. 199. 2017
Editorial Comment.. 198. 2017
Editorial Comment.. 196. 2016
Editorial Comment.. 196. 2016
Editorial comment.. 185. 2011
Re: Artificial urinary sphincter in children-voiding or emptying? An evaluation of functional results in 44 patients M. Catti, S. Lortat-Jacob, M. Morineau and H. Lottmann J Urol 2008; 180: 690-693.. 181. 2009
Re: laparoscopic radical nephrectomy: cancer control for renal cell carcinoma.. 168. 2002
Genetic alterations in prostate cancer.. 162. 1999
This month in investigative urology: Round spermatid nuclei and embryonic development.. 158. 1997
Re: Accuracy of ultrasound diagnosis after blunt testicular trauma.. 152. 1994
Editorial Comment. 2025
Editorial Comment. 2024
Reply by Authors. 2023
Reply by Authors. 2022
Reply by Authors. 2021
Reply by Authors. 2021
Reply by Authors. 2021
Reply by Authors. 2020
Reply by Authors. 2019
Reply by Authors. 2019
Reply by Authors. 2019
Editorial Comment. 2019
Reply by Authors. 2019
Re: Marijuana Use in Transplantation: A Call for Clarity. 2019
Re: Surgical Approach Does Not Impact Margin Status after Partial Nephrectomy for Large Renal Masses. 2019
Reply by Authors. 2019
Re: Impact of Ureteral Stricture and Treatment Choice on Long-Term Graft Survival in Kidney Transplantation. 2019
Re: Dopamine in Transplantation: 2019
Re: Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: .: H. E. Foster, M. J. Barry, P. Dahm, M. C. Gandhi, S. A. Kaplan, T. S. Kohler, L. B. Lerner, D. J. Lightner, J. K. Parsons, C. G. Roehrborn, C. Welliver, T. J. Wilt and K. T. McVary J Urol 2018; 200: 612-619. 2019
Re: Potential Yield of Imminent Death Kidney Donation. 2018
Re: Shipping Living Donor Kidneys and Transplant Recipient Outcomes. 2018
Re: Urologic Malignancies in Kidney Transplantation. 2018
Re: Use and Outcomes of Kidneys from Donation after Circulatory Death Donors in the United States. 2018
Re: Robot-Assisted Kidney Transplantation: The European Experience. 2018
Re: Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients. 2018
Re: New Insights into the Alleged Kidney Donor Profile Index Labeling Effect on Kidney Utilization. 2018
Editorial Comment. 2017
Re: A Cost Comparison for Telehealth Utilization in the Kidney Transplant Waitlist Evaluation Process. 2017
Re: Telemedically Supported Case Management of Living-Donor Renal Transplant Recipients to Optimize Routine Evidence-Based Aftercare: A Single-Center Randomized Controlled Trial. 2017
Re: Big Data, Predictive Analytics, and Quality Improvement in Kidney Transplantation: A Proof of Concept. 2017
Re: Remote Ischemic Conditioning on Recipients of Deceased Renal Transplants Does Not Improve Early Graft Function: A Multicenter Randomized, Controlled Clinical Trial. 2017
Re: Continuous Normothermic Ex Vivo Kidney Perfusion is Superior to Brief Normothermic Perfusion following Static Cold Storage in Donation after Circulatory Death Pig Kidney Transplantation. 2017
Editorial Comment. 2017
Re: Eight-Hour Continuous Normothermic Ex Vivo Kidney Perfusion is a Safe Preservation Technique for Kidney Transplantation: A New Opportunity for the Storage, Assessment, and Repair of Kidney Grafts. 2017
Re: Coronary Calcium Score May Replace Cardiovascular Risk Factors as Primary Risk Stratification Tool before Kidney Transplantation. 2017
The Camey Procedure. 2016
Editorial Comment. 2016
Re: Live Donor Renal Transplant with Simultaneous Bilateral Nephrectomy for Autosomal Dominant Polycystic Kidney Disease is Feasible and Satisfactory at Long-Term Follow-up. 2016
Re: Obstetric and Neonatal Outcome of Pregnancies Fathered by Males on Immunosuppression after Solid Organ Transplantation. 2015
Re: ABO Incompatible Renal Transplantation without Antibody Removal Using Conventional Immunosuppression Alone. 2015
Re: frailty and early hospital readmission after kidney transplantation. 2014
Re: a single-center analysis of abdominal imaging in the evaluation of kidney transplant recipients. 2014
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. 2013
Re: Renal transplantation after ex vivo normothermic perfusion: the first clinical study. 2013
Re: Debilitating lower urinary tract symptoms in the post-renal transplant population can be predicted pretransplantation. 2013
Re: early hospital readmission after kidney transplantation: patient and center-level associations. 2013
Re: de novo kidney graft tumors: results from a multicentric retrospective national study. 2013
Re: Value of routine voiding cystourethrography after renal transplantation. 2013
Re: long-term results of biopsy-guided selection and allocation of kidneys from older donors in older recipients. 2013
Re: Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure. 2013
Re: kidney transplant ureteroneocystostomy: comparison of full-thickness vs. Lich-Gregoir techniques. 2012
Re: pulsatile pump decreases risk of delayed graft function in kidneys donated after cardiac death. 2012
Re: A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. 2012
Re: Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation. 2012
Re: Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. 2012
Re: Current status of organ transplantation in Japan. 2012
Re: A simplified donor risk index for predicting outcome after deceased donor kidney transplantation. 2012
Re: Influence of CIT-induced DGF on kidney transplant outcomes. 2012
Re: Renovascular resistance of machine-perfused DCD kidneys is associated with primary non-function. 2012
Re: donor kidney adapts to body dimensions of recipient: no influence of donor gender on renal function after transplantation. 2012
Re: the prognostic value of renal resistance during hypothermic machine perfusion of deceased donor kidneys. 2012
Re: desensitization in HLA-incompatible kidney recipients and survival. 2012
Re: first in man renal transplantation after ex vivo normothermic perfusion. 2012
Re: effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. 2011
Re: laparoscopic kidney transplantation: an initial experience. 2011
Re: Native nephrectomy for renal cell carcinoma in transplant recipients. 2011
Re: Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis. 2011
Re: Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes. 2011
Renal transplantation and renovascular hypertension. 2010
Laparoscopic live donor nephrectomy: a risk factor for delayed function and rejection in pediatric kidney recipients? A UNOS analysis. 2005
Donor kidney exchanges. 2005
Tissue engineering stem cells, and cloning: opportunities for regenerative medicine. 2005
Current recommendations for delaying renal transplantation after localized prostate cancer treatment: are they still appropriate? 2005
Stented versus nonstented extravesical ureteroneocystostomy in renal transplantation: a metaanalysis. 2005
Ureteral necrosis after kidney transplantation: risk factors and impact on graft and patient survival. 2005
Death in the first year after kidney transplantation: implications for patients on the transplant waiting list. 2003
Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation? 2003
Prevalence of renovascular disease in the elderly: a population-based study. 2003
Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies. 2003
Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings. 2003
Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. 2003
Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. 2003
Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. 2003
Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. 2003
Use of heparin and protamine sulfate during laparoscopic donor nephrectomy. 2003
Are wound complications after a kidney transplant more common with modern immunosuppression? 2002
Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. 2002
Kidney transplantation in children weighing less than 15 kg: donor selection and technical considerations. 2002
Nonsurgical treatment of acute iatrogenic renal artery injuries occurring after renal artery angioplasty and stenting. 2002
Pancreas after kidney transplants. 2002
Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Reply. 2023
Current Landscape of Surgical Assessment Models in Urology Residency Training. Reply. 2023
National Adherence to Guidelines for Antimicrobial Prophylaxis for Patients Undergoing Radical Cystectomy. Reply. 2023
A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup. Letter. 2022
Tobacco Screening and Treatment during Outpatient Urology Office Visits in the United States. Letter.J Urol 2021; 205: 1755. 2021
Re: Recent Changes in Prostate Cancer Screening Practices and Epidemiology: D. J. Lee, K. Mallin, A. J. Graves, S. S. Chang, D. F. Penson, M. J. Resnick and D. A. Barocas J Urol 2017;198:1230-1240. 2018
Re: Editorial comment. D. A. Canning, J Urol 2006; 176: 2242. 2007
Re: Is tumor volume an independent prognostic factor in clinically localized prostate cancer? 2005
Re: acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers. 2005
Re: Continuous versus intermittent bladder irrigation of amphotericin B for the treatment of candiduria. 1996
Re: Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. 1994
Re: Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma. 1994
Re: Ketoconazole therapy for fungal urinary tract infections. 1984
Renal candidiasis in the neonate. 1982
Re: in vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study. 1982
Hospital-Level Patterns of Retroperitoneal Lymph Node Dissection Surgeries: Are Recommendations for High-Volume Centralization Being Followed?. 213. 2025
Editorial Comment.. 212. 2024
Editorial Comment.. 212. 2024
Prostate Artery Embolization for Benign Prostatic Hyperplasia.. 212. 2024
Editorial Comment.. 208. 2022
Preoperative Testosterone for Hypospadias: What's the Goal? 2022
Editorial Comment.. 207. 2021
Editorial Comment.. 207. 2021
Editorial Comment.. 206. 2021
Understanding the True Prevalence of Prostate Cancer Genomic Subtypes: Use of Inverse Probability Weighting to Correct for Biases in Molecularly Profiled Cohorts.. 205. 2021
Urology Chief Resident Turned Medicine Intern: Experience during the COVID-19 New York City Pandemic.. 204. 2020
The Most Important Lesson I Learned this Year.. 200. 2018
Editorial Comment.. 196. 2016
Are Some Cases of Somatic Type Malignancy Potentially Avoidable?. 196. 2016
Editorial Comment.. 195. 2016
Should Fluorescence Mapping be Used to Guide Pelvic Lymph Node Dissection?. 194. 2015
Re: Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.. 193. 2014
Editorial comment.. 193. 2014
Re: Transplantation between monozygotic twins: how identical are they?. 193. 2014
Management of complications and residual symptoms in men with an artificial urinary sphincter.. 192. 2014
Re: The decline in living kidney donation in the United States: random variation or cause for concern?. 192. 2014
Re: the use of fosfomycin to treat urinary tract infections in kidney transplant recipients.. 191. 2013
Re: evaluation of potential renal transplant recipients with computed tomography angiography.. 191. 2013
Evolution of novel biomarkers for detection of prostate cancer.. 190. 2013
Editorial comment.. 190. 2013
Robotic salvage prostatectomy: underused but not for the inexperienced.. 189. 2012
Expectant management of localized prostate cancer--who, what, when, where and how?. 188. 2012
Re: Ureteral stents are associated with reduced risk of ureteral complications after kidney transplantation: a large single center experience.. 188. 2012
Editorial comment.. 188. 2012
Editorial comment.. 187. 2012
Editorial comment.. 185. 2010
Assessing urological complications of radiation therapy and surgical approaches for repair.. 184. 2010
Editorial comment.. 183. 2010
Editorial comment.. 182. 2009
Editorial comment.. 182. 2009
Female stress urinary incontinence--where are we?. 179. 2008
Ureteral obstruction and stents: still a difficult problem for patients and urologists alike.. 174. 2005
Percutaneous, image guided urological procedures: barbarians at the gate.. 174. 2005
Continuing refinements in radical prostatectomy: more evidence that technique matters.. 173. 2005
Editorial: predicting necrosis after chemotherapy for advanced nonseminomatous germ cell tumor-surrogate end points, decreasing morbidity and patient outcome.. 171. 2004
Editorial: States and state transitions are all that really matter.. 168. 2002
Imaging prostate cancer.. 162. 1999
Towards a better crystal ball.. 160. 1998
Prostate cancer--staging and prognosis.. 155. 1996
Vasectomy and extracorporeal shock wave lithotripsy hurt-limit varicocelectomy procedures--To transurethral resection or not?. 155. 1996
Prostate cancer.. 154. 1995
Urinary reconstruction and diversion.. 154. 1995
Oncological outcomes after radical cystectomy for bladder cancer: open versus minimally invasive approaches. 2010
Systemic therapy for renal cell carcinoma. 2000
Combination Strategies to Enhance Bacillus Calmette-Guérin Efficacy for Nonmuscle-Invasive Bladder Cancer. 2025
Current Landscape of Surgical Assessment Models in Urology Residency Training. 2022
Erectile Dysfunction is a Transient Complication of Prostate Biopsy: A Systematic Review and Meta-Analysis. 2020
Future Directions of Research and Care for Urinary Incontinence: Findings from the National Institute of Diabetes and Digestive and Kidney Diseases Summit on Urinary Incontinence Clinical Research in Women. 2017
The Role of the 24-Hour Urine Collection in the Prevention of Kidney Stone Recurrence. 2016
Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above. 2016
Gleason 6 Prostate Cancer: Translating Biology into Population Health. 2015
Contemporary applications and limitations of magnetic resonance imaging contrast materials. 2010
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. 2007
Bone health in men receiving androgen deprivation therapy for prostate cancer. 2007
Hypogonadism and metabolic syndrome: implications for testosterone therapy. 2005
Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen. 2003
The role of caveolin-1 in androgen insensitive prostate cancer. 2002
Society of Urologic Oncology Biotechnology Forum: new approaches and targets for advanced prostate cancer. 2001
A catalog of prostate cancer nomograms. 2001
Testicular position in the androgen insensitivity syndrome: implications for the role of androgens in testicular descent. 2000
Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. 1998
Risk factors for complications and morbidity after radical retropubic prostatectomy. 1997
Surgery for a post-chemotherapy residual mass in seminoma. 1997
Risk factors for urinary incontinence after radical prostatectomy. 1996
Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world. 1995
The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. 1995
The use of prostate specific antigen for prostate cancer screening: a managed care perspective. 1994
Fungal infections of the genitourinary system. 1993
Amphotericin B in urological practice. 1990
Monoclonal antibodies: state of the art. 1987
Magnetic resonance imaging in urology. 1984
Medical management of kidney stones: AUA guideline. 2014
Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. 2013

VIVO Weill Cornell Medical College

The Journal of urology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)